Astrazeneca Plc ADR (AZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Sales | 22,090,000 | 22,465,000 | 23,002,000 | 24,708,000 | 26,547,000 |
| Cost of Goods | 4,936,000 | 4,318,000 | 4,126,000 | 4,646,000 | 5,842,000 |
| Gross Profit | 17,154,000 | 18,147,000 | 18,876,000 | 20,062,000 | 20,705,000 |
| Operating Expenses | 13,767,000 | 14,470,000 | 13,974,000 | 15,948,000 | 18,568,000 |
| Operating Income | 3,387,000 | 3,677,000 | 4,902,000 | 4,114,000 | 2,137,000 |
| Interest Expense | 1,419,000 | 1,508,000 | 1,384,000 | 1,075,000 | 963,000 |
| Other Income | 25,000 | 58,000 | 34,000 | 30,000 | 72,000 |
| Pre-tax Income | 1,993,000 | 2,227,000 | 3,552,000 | 3,069,000 | 1,246,000 |
| Income Tax | -57,000 | -641,000 | 146,000 | 243,000 | 11,000 |
| Net Income Continuous | 2,050,000 | 2,868,000 | 3,406,000 | 2,826,000 | 1,235,000 |
| Minority Interests | -105,000 | -133,000 | -93,000 | 1,000 | 2,000 |
| Net Income | $2,155,000 | $3,001,000 | $3,499,000 | $2,825,000 | $1,233,000 |
| EPS Basic Total Ops | 0.85 | 1.19 | 1.39 | 1.12 | 0.49 |
| EPS Basic Continuous Ops | 0.81 | 1.13 | 1.35 | 1.12 | 0.49 |
| EPS Diluted Total Ops | 0.85 | 1.19 | 1.38 | 1.12 | 0.49 |
| EPS Diluted Continuous Ops | 0.81 | 1.13 | 1.35 | 1.12 | 0.49 |
| EPS Diluted Before Non-Recurring Items | 1.73 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $7,140,000 | $6,713,000 | $7,259,000 | $6,966,000 | $5,419,000 |